Effector Therapeutics Inc (EFTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 427 | 692 | 0 | 0 | 574 |
| Gross Profit | 427 | 692 | N/A | N/A | 574 |
| Operating Expenses | 9,141 | 5,736 | 5,737 | 0 | 7,843 |
| Operating Income | -8,714 | -5,044 | -5,737 | N/A | -7,269 |
| Interest Expense | 488 | 480 | 306 | 0 | 342 |
| Other Income | 18,081 | -24 | -539 | 0 | 7 |
| Pre-tax Income | 8,879 | -5,548 | -6,582 | 0 | -7,604 |
| Income Tax | N/A | N/A | N/A | N/A | 5 |
| Net Income Continuous | 8,879 | -5,548 | -6,582 | N/A | -7,609 |
| Net Income | $8,879 | $-5,548 | $-6,582 | $N/A | $-7,609 |
| EPS Basic Total Ops | 13.25 | -95.75 | -113.75 | N/A | -132.25 |
| EPS Basic Continuous Ops | 13.29 | -95.66 | -113.88 | N/A | -132.19 |
| EPS Diluted Total Ops | 10.50 | -95.75 | -113.75 | N/A | -132.25 |
| EPS Diluted Continuous Ops | 11.06 | -95.66 | -113.88 | N/A | -132.19 |
| EBITDA(a) | $-8,708 | $-5,038 | $-5,730 | $N/A | $-7,269 |